• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.10% Nasdaq Up 0.21%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    6.71 Up 0.07(1.05%) 10:49AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:6.64
    Open:6.62
    Bid:6.66 x 3800
    Ask:6.67 x 8000
    1y Target Est:7.00
    Beta:0.62
    Earnings Date:Aug 17 - Aug 21 (Est.)
    Day's Range:6.61 - 6.71
    52wk Range:6.38 - 10.26
    Volume:307,278
    Avg Vol (3m):4,042,160
    Market Cap:1.10B
    P/E (ttm):3.50
    EPS (ttm):1.92
    Div & Yield:0.60 (9.00%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PDLIUp 1.05%1.10B
    AMGNUp 0.14%124.75B
    SGENDown 0.55%5.44B
    XOMAUp 1.01%403.43M

    Key Statistics

    Forward P/E (1 yr):8.44
    P/S (ttm):2.18
    Ex-Dividend Date:02-Dec-15

    Analysts

    Annual EPS Est (Dec-15) :2.11
    Quarterly EPS Est (Jun-15) :0.52
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.22

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback